Menu Close

Category: Daily News

Walmart Sues 45 National Carriers For Opioid Settlement Costs

Walmart claims in Arkansas state court that 45 of the nations largest insurers wrongly refused to cover losses incurred as a result of defending itself against more than 2,400 opioid lawsuits. Jurisdiction in Arkansas is claimed because Walmart is headquartered in Bentonville, Arkansas, and the parties conduct business in Arkansas, including the Insurers selling insurance to Walmart in Benton County, Arkansas.

This action involves nearly 200 insurance policies spanning two decades, and many of those policies are dozens or hundreds of pages long.

According to the Complaint they failed, they allege that Walmart has paid millions of dollars to 45 Defendant Insurers – many of the nation’s leading insurance companies – for broad general liability policies designed to protect Walmart against potential risks to its business.

They say those risks have now manifested themselves in the form of more than 2,400 Opioid Lawsuits that have been filed against Walmart. Those lawsuits seek damages because of, among other things, bodily injuries allegedly arising out of opioids or opioidcontaining products that Walmart sold, distributed, or dispensed.

Walmart claims it has spent tens of millions of dollars defending itself against the Opioid Lawsuits and expects to spend much more in the future. Walmart timely notified the Insurers of each of the Opioid Lawsuits. But now they say “the Insurers have turned their backs, providing a litany of excuses why the policies supposedly do not cover the Opioid Lawsuits.”

Those excuses are meritless, as Walmart has repeatedly explained to Insurers, yet they continue to refuse to live up to their obligations under the policies.” And they go on to claim that “the underlying Opioid Lawsuits seek damages sufficient to exhaust all layers of coverage provided by Insurers’ Policies.”.

“Insurers have either reserved their rights to deny coverage, denied their duties to defend or indemnify, and/or otherwise failed to acknowledge their obligations to provide coverage for the Opioid Lawsuits on a series of baseless grounds.”

“For example, certain Insurers have asserted that these lawsuits are not brought “because of bodily injury,” despite complaints and settlements expressly stating otherwise and making clear that the underlying plaintiffs’ alleged damages are because of alleged injury and death to hundreds of thousands of individuals as a result of opioid abuse and addiction.”

“Certain Insurers have also asserted that coverage for the Opioid Lawsuits is excluded because the damages at issue in them were “expected or intended,” even though these lawsuits include numerous allegations of negligent or otherwise unintentional conduct or injuries, many of the settlements are expressly based on negligent conduct, not intentional harm, and Walmart has vehemently denied that it intended or expected to harm anyone.”

Many of the Policies are “primary” or first-level policies, meaning that they obligate the issuing Insurers to defend or to pay for Walmart’s defense and to indemnify Walmart either from the first dollar spent, or once a self-insured retention is satisfied. Those policies were issued by Defendants National Union, American Home, and the Insurance Company of the State of Pennsylvania.

Other Policies are umbrella or excess-layer policies, which, among other things, obligate the issuing Insurers to defend or to pay for Walmart’s defense costs and/or to indemnify Walmart for settlement or judgment costs when those costs exceed specified retention amounts or amounts of coverage available under lower-layer Policies or when coverage is not available or not collectible from such lower-layer Policies. The umbrella and excess-layer Policies were issued by various Insurers.

WCIRB Releases- 2022 Geo Study with Interactive Map

The Workers’ Compensation Insurance Rating Bureau of California (WCIRB) released the 2022 WCIRB Geo Study, which underscores regional differences in claim characteristics across California. The web-based interactive map allows you to quickly view key measures across regions.

The study, related exhibits and mapping of nine-digit zip codes o the regions referenced in the study are available in the Research section of the WCIRB website.

Key findings include:

– – Even after controlling for regional differences in wages and industry mix, indemnity claim frequency is significantly higher in the Los Angeles (LA) Basin and significantly lower in the San Francisco Bay Area.
– – During the pandemic, indemnity claim frequency increased significantly in Orange County relative to the rest of the state and decreased significantly in Ventura and Santa Monica/San Fernando Valley.
– – The share of open indemnity claims has decreased substantially in all regions since 2013. The decreases have been larger in the LA Basin regions that had the highest initial open indemnity claim shares.
– – The share of larger indemnity claims (those with incurred costs greater than $250,000) at third report level tends to be higher in regions that have lower indemnity frequency. Northern California regions, including the Bay Area and Peninsula/Silicon Valley, tend to have higher shares of larger indemnity claims.
– – During the pandemic, the median injured worker’s average weekly wage increased significantly in all regions. The increases were largest in Fresno/Madera, San Gabriel Valley/Pasadena, Santa Monica/San Fernando Valley and Tulare/Inyo. The median wage in these regions has often been lower than the statewide average.
– – The share of cumulative trauma claims as a percent of all claims increased for all regions during the pandemic. The increase was largest in San Bernardino/West Riverside and LA/Long Beach which also have high relative frequency of indemnity claims. It was also relatively high in the Bay area and Sonoma/Napa which saw decreases in the relative frequency of indemnity claims.
– – Medical-legal costs are significantly higher in the LA Basin, Orange County and Santa Monica/San Fernando Valley regions than in the remainder of the state.
– – Paid allocated loss adjustment expenses (ALAE) are significantly higher in Southern California regions.
– – In 2020, nearly one in eight indemnity claims reported in California were due to COVID-19. Shares of COVID-19 claims were higher in Southern California.
– – Average weekly wages for workers with COVID-19 claims were significantly higher than average weekly wages for workers with non-COVID-19 claims in all regions. The differences were greatest in the Ventura, San Bernardino/West Riverside and San Diego regions.

The WCIRB will host a free webinar to discuss the 2022 WCIRB Geo Study. Click on the registration link to sign up. Please submit your questions while registering; time permitting, we will answer your questions during the webinar or follow up via email afterward. – Wednesday, December 7, 2022, 10:00 AM – 11:00 AM PT. WCIRB Presenters: Dave Bellusci, Executive Vice President and Chief Actuary; Laura Carstensen, Vice President, Actuarial Research; and Shane Steele, Research Actuary.

For those unable to attend the live webinar, a recording will be posted in the Research section of the WCIRB website following the event.

WCAB Defines “High Velocity Eye Injury” Required for Extended TTD

Andrew Glick claimed injury to his left knee, lumbar spine, neurological system, and “ophthalmology/vision/eye,” while employed as a truck driver by Knight-Swift Transportation Holdings, Inc. when he was injured on November 26, 2018.

Glick was struck by a motor vehicle while crossing the street. The vehicle was traveling at approximately 30 miles per hour at the time of impact, and he was thrown approximately 10 feet, landing on the ground on his left side. Glick was knocked unconscious, and was transported by ambulance to Riverside Community Hospital, where he was diagnosed as having sustained a fractured left tibia, left fibula, left femur, right scapula, right clavicle, right and left temporal bones, L1 vertebrae, L2 vertebrae, L3 vertebrae, L4 vertebrae, and a left “brain bleed.”

On June 9, 2020 the Qualified Medical Evaluator (QME) in Physical Medicine and Rehabilitation noted his “number one problem” was vision difficulty:” The report said that “He was told he has nerve damage behind the right eye, so if he drives or does activities requiring any kind of balance or proprioception, he closes the right eye and only uses the left.” Mr Glick remained temporarily totally disabled.

A QME in ophthalmology reported in August 2020 that he was “not yet permanent and stationary, and required a strabismus (eye muscle) surgery to address superior oblique palsy, because “[t]he function of the 4th nerve cannot be restored.”

After an Expedited Hearing on the issue of whether Mr. Glick was entitled to temporary disability continuing from the last date paid of approximately 11/24/20 and continuing, pursuant to the applicability of Labor Code § 4656 (c)(3)(F), the WCJ issued his F&A, finding that Glick sustained injury to the “ophthalmology/vision/eye,” caused by a “high velocity impact,” resulting in “temporary total disability for which defendant has paid 104 weeks and which said benefit is ongoing.” The WCJ found defendant liable for ongoing temporary total disability pursuant to Labor Code section 4656(c)(3)(F).

Reconsideration of this Award was denied in the panel decision of Glick v Knight-Swift Transportation Holdings, Inc – ADJ11799924 (November 2022).

The WCJ filed his Report, observing that the statutory requirements were met because applicant sustained a high velocity impact to his person, which was the direct cause of both a concussion and a resulting eye injury.

The employer contended that the “plain language or common meaning” of the term “high-velocity eye injuries,” as set forth in Labor Code section 4656(c)(3)(F) refers to “at least some impact of the eye.” And cites as authority Cruz v. Mercedes-Benz of San Francisco (2007) 72 Cal. Comp. Cases 1281 [2007 Cal. Wrk. Comp. LEXIS 247] (Appeals Bd. en banc), were the WCAB applied a “common sense and ordinary meaning” to the term “amputation,” and that a similar analysis of section 4656(c)(2)(F) requires there be “some impact to the eye.”

Andrew Glick cites Glover v. ACCU Construction (June 15, 2009, ADJ665716 (BAK 0154393) [2009 Cal. Wrk. Comp. P.D. LEXIS 301] Glover was operating a mulching mower when he was struck by a metal fragment that entered his nostril, lacerating the nose and fracturing the eye socket before traveling through the brain and lodging in the back of the skull. In Glover the panel concluded “We are not persuaded that “eye” should be defined so narrowly, yet we need not delineate the outer limits of our definition at this time. We have examined applicant’s medical records and find ample evidence of injury to and treatment of the right eye.”

Turning to the issues in the claim of Mr. Glick, the panel followed its reasoning in Glover and concluded “Here, the facts support a similar analysis.”

Walgreens VillageMD to buy Summit Health for $9B

VillageMD, which is majority owned by Walgreens Boots Alliance, plans to pay nearly $9 billion to pick up medical practice Summit Health, the parent company of urgent care clinic chain CityMD.

According to the report by Fierce Healthcare, the deal, announced Monday morning, is valued at $8.9 billion and includes investments from Walgreens Boots Alliance and Cigna Corp’s healthcare unit Evernorth, which will also become a minority owner in VillageMD.

The deal will expand Walgreen’s reach into primary, specialty and urgent care. The transaction creates one of the largest independent provider groups in the U.S., the organizations said. Combined, VillageMD and Summit Health will operate more than 680 provider locations in 26 markets. The two companies will have 20,000 employees.

Last year, Walgreens invested $5.2 billion in VillageMD and said it planned to open at least 600 Village Medical at Walgreens primary-care practices across the country by 2025 and 1,000 by 2027.

The deal comes amid a frenzy of Merger and Acquisition activity in the past two years. Major retailers like CVS, Walgreens and Amazon are ramping up their focus on providing medical services to gain bigger footholds in the healthcare market.

Drugstore rival CVS Health won the bidding war for home health and technology services company Signify Health and plans to shell out $8 billion to acquire the company. Amazon also plans to buy primary care provider One Medical for $3.9 billion.

The move signals that Walgreens wants to become a “dominant entity in the overall healthcare services ecosystem,” according to David Larsen, healthcare IT and digital health analyst at financial services firm BTIG.

“Walgreens Boots Alliance is graduating up from being a drug retail store to owning the life-cycle of members’ health,” he wrote in an analyst’s note. “We view this transaction as being a statement by the market that primary care continues to be one of the key drivers of healthcare long-term.”

The deal also will put additional pressure on CVS Health to break into the primary care business “sooner rather than later,” Larsen wrote.

VillageMD provides value-based primary care for patients at traditional free-standing practices, Village Medical at Walgreens practices, at home and via virtual visits. VillageMD and Village Medical have grown to 22 markets and are responsible for more than 1.6 million patients, according to the company.

The acquisition also expands Walgreens’ reach into providing medical care directly to patients. “This transaction accelerates growth opportunities through a strong market footprint and wide network of providers and patients across primary, specialty and urgent care,” Roz Brewer, CEO of Walgreens Boots Alliance, said in a statement.

NCCI Publishes Update to 2021 State of the WC Line Report

At its Annual Insights Symposium (AIS) in May 2022, NCCI presented the State of the Line Report – a comprehensive account of financial results for the workers compensation (WC) line of business. The results presented in that report reflected the most current data available at the time, including NCCI’s preliminary estimates for Calendar Year 2021.

In this new report, NCCI provided updated results for 2021, as well as preliminary information for 2022.

For Calendar Year 2021, NCCI previously estimated WC written premium volume net of reinsurance (NWP) to be $38.3 billion for private carriers. The most recently reported industry data for that year is $38.2 billion, which represents a 0.5% increase from 2020’s NWP volume of $38.0 billion.

For Calendar Year 2021, NCCI previously estimated a WC net combined ratio of 87% for private carriers. Updated industry data indicates a net combined ratio of 87.2%, which represents a 12.8% underwriting gain.

The 2021 combined ratio is the fourth lowest combined ratio in recent history and the eighth consecutive underwriting gain for the WC industry. The current period of consecutive underwriting gains is unprecedented in terms of both duration and magnitude.

The 2021 combined ratio is the fourth lowest combined ratio in recent history and the eighth consecutive underwriting gain for the WC industry. The current period of consecutive underwriting gains is unprecedented in terms of both duration and magnitude.

The WC pretax operating gain measures the overall financial performance of the WC line of business, reflecting both underwriting and investment income. The Calendar Year 2021 underwriting gain of 12.8%, combined with the investment gain of 10.9%, resulted in a WC operating gain of 23.7% for that year. This value is slightly lower than the preliminary estimate of 25% shared at AIS 2022 and marks the fifth consecutive operating gain exceeding 20% for the WC industry.

Changes in rates/loss costs impact premium growth and are one of several factors, such as changes in the economy, cost containment initiatives, and reforms that may impact overall system costs. All else being equal, NCCI expects premium to decrease in 2022 by 7.5%, on average, as a result of rate/loss cost filings made in jurisdictions for which NCCI provides ratemaking services. Improved experience driven by long-term declines in lost-time claim frequency has contributed to this decrease. The changes shown below reflect both voluntary and assigned risk market approvals.

Orange County Cities Consider Protections for Hospitality Workers

In recent years several cities, including Los Angeles and West Hollywood have passed hotel worker protection ordinances, which put both safety and workload protections in place.

Laguna Beach voters this November will also decide on Measure S which would implement protections for hotel workers as well as make minimum wage for hotel workers in the city $18 an hour.

The city of Irvine may be joining this trend. On October 25th, the Irvine City Council voted by a close margin to pass a hotel worker protection ordinance. The ordinance still must pass a second reading vote, in order to become effective. To date, the second reading has not been scheduled.

In a 3-2 vote the members of the Irvine City Council became the first city in Orange County to approve an ordinance that aims to improve workplace protection for hospitality workers in Irvine.

During a City Council special meeting, a report by Irvine Weekly said that local hospitality workers, many of them speaking through a translator during public comment, shared personal experiences that detailed occurrences of repeated propositions for sex and frequent unwanted physical advances from hotel guests toward hospitality staff. Many public speakers said they experience this type of inhumane treatment on a regular basis.

Now, the Hotel Worker Protection Ordinance will make it the responsibility of hotel management to equip and maintain wearable security devices for staff to utilize in the event someone is harassed, assaulted or in an emergency. Based on the size of a hotel, the Ordinance would also establish maximum room cleaning quotas for hotel staff.

While the ordinance was heavily supported by hospitality industry employees, several hotel managers spoke against the ordinance.

Donald Driscoll, General Manager of The DoubleTree by Hilton Irvine Spectrum, wrote a letter addressed to Irvine City Clerk, Carl Pertersen. In his letter, Mr. Driscoll asked the council to withdraw from a vote, citing that a vote without any hospitality industry ownership involvement is “inappropriate and undemocratic.”

“Our hotel has gone over three hundred days without a lost-time workplace accident, and we pride ourselves on monitoring and maintaining a safe environment for both team members and our guests,” he wrote. “We also provide weekly and daily safety reminders and share these with all team members to keep safety and safe work practices front of mind for all.”

Lynn S. Mohrfeld, President and CEO of the California Hotel and Lodging Association (CHLA) , wrote a letter echoing Mr. Driscoll’s statements. Both letters were submitted into the e-comments prior to the meeting.

Mohrfeld said she was concerned that the new ordinance would impact scheduling, if rooms are made unavailable due to new cleaning mandates.

“CHLA and our Irvine hotel community are extremely concerned that the proposed ordinance you’re considering is not motivated by worker safety concerns. We are also extremely concerned that this ordinance would harm the hospitality industry and our employees who are still recovering from nearly two years of pandemic-related closures that set us and the city back months,” Mohrfeld stated.

DOI has Jurisdiction to Invalidate Carrier “Unfiled” Side Agreements

Adir operates the Curacao chain of retail department stores. Between 2004 to 2011 Travelers issued Adir annual guaranteed cost workers’ compensation insurance policies. Each policy was filed with the Workers Compensation Rating Bureau (WCRB) pursuant to Insurance Code section 11658 and specified the rates to be charged to Adir.

In 2012 Adir did not renew its workers’ compensation insurance with Travelers and refused to pay Travelers’ post-policy period adjusted premiums as required by the side agreements.

After negotiations to recover premiums Adir owned under the large risk alternative rating plan failed, Travelers in 2014 served Adir with an arbitration demand. In response Adir filed an action in Los Angeles County Superior Court (L.A.S.C. No. BC575513) against Travelers and its insurance broker, Grosslight Insurance, asserting claims for breach of contract, tortious breach of the implied covenant of good faith and fair dealing and fraud.

The case proceeded in various forums, at various times, In one of the forums, Adir on April 22, 2016 filed an administrative appeal (and on June 2, 2016 a supplemental appeal) with the Department of Insurance pursuant to section 11737, subdivision (f), which authorizes a person aggrieved by application of a rating system to appeal to the Commissioner. In response Travelers petitioned for a writ of prohibition in the pending trial court action requesting the court stay the administrative hearing while the lawsuit was pending. The court denied the petition.

The Commissioner concluded that the Department of Insurance had “exclusive jurisdiction [pursuant to section 11737, subdivision (f)], to adjudicate [Adir]’s claim that Travelers’ unfiled Side Agreements misapplied Travelers’ filed rating plan by violating Insurance Code sections 11658 and 11735, as well as California Code of Regulations, title 10, section 2268.” On the merits the Commissioner ruled Travelers’ side agreements were void because they had not been filed with the WCRB as required and constituted a misapplication of Travelers’ filed rating plan in violation of sections 11658 and 11735.

Travelers filed a petition for a writ of administrative mandate challenging the Commissioner’s decision which was denied by the Superior Court, The Court of Appeal affirmed the Commissioner’s Order as well as the postjudgment order granting Adir’s motion for attorney fees, in the published case of The Travelers Indemnity Co., v Lara – B306897 (November 2022).

Travelers contends the Commissioner acted in excess of his jurisdiction by deciding Adir’s administrative appeal while Adir’s trial court action was pending. Citing the rule of exclusive concurrent jurisdiction applicable between two judicial tribunals. This rule provides that where several courts have concurrent jurisdiction of a certain type of proceeding, the first one to assume and exercise such jurisdiction in a particular case acquires an exclusive jurisdiction.

However, the Court of Appeal noted that there is “some doubt whether the rule of exclusive concurrent jurisdiction applies here.” The “judge-made rule” of exclusive concurrent jurisdiction “is based upon the public policies of avoiding conflicts that might arise between courts if they were free to make contradictory decisions or awards relating to the same controversy.”

“Because it is a policy rule, application of the rule depends upon the balancing of countervailing policies.” The exclusive concurrent jurisdiction doctrine does not apply in this context to proceedings pending before the trial court and an administrative agency; and, in any event, it was reasonable and consistent with the primary jurisdiction doctrine for the trial court to defer to the Commissioner’s determination of the validity of the agreement at issue.

Santa Rosa Neurosurgeon Convicted for Opioid Prescriptions

A federal jury convicted former physician Thomas McNeese Keller of four counts of distributing controlled substances, including Oxycodone, Carisoprodol and Diazepam, outside the scope of his professional practice and without a legitimate medical need.

Keller, 75, was a Santa Rosa resident and a licensed physician who ran a pain management practice in Santa Rosa when he was indicted in this current case on September 27, 2018.

Keller, a former Army neurosurgeon, had a checkered medical career. He was found to have engaged in sexual misconduct with several patients in 1989, for which he served six months in jail. He also was temporarily stripped of his license, which was eventually reinstated in 1994.

He opened his Santa Rosa medical practice in 2008, and started focusing on pain management about three years later. He suspended his medical practice in fall 2018, after learning that federal authorities were investigating him in connection with health care fraud and illegally distributing opioids.

He was arrested in August, 2019 and faced multiple charges brought by the California Attorney General’s Office, including second-degree murder in the deaths of four Sonoma County residents. Tripo Nelson, Ashlee McDonald, Dean Rielli and Jerri Lee Badenhop-Bionda all who died in 2016 or 2017 from drug overdoses while under Keller’s care. In May 2020, After nearly a week of deliberation, a jury found that Keller was not guilty of second-degree murder in the deaths of two of his patients but failed to reach a verdict on several other charges.

He then faced the current charges filed by prosecutors in federal court. At trial, the evidence demonstrated that Keller repeatedly prescribed the opioid oxycodone and other strong, addictive drugs to his patient, A.M., in dosages that far exceeded the usual course of professional practice and was for no legitimate medical need.

Trial evidence showed that on December 22, 2016, Keller prescribed Oxycodone, Diazepam, and Carisoprodol at the same time to A.M., knowing she did not need such a dangerous combination of drugs.

Evidence also showed that on January 20, 2017, Keller again distributed Diazepam, often called Valium, to A.M., and on February 16, 2017, distributed Oxycodone to A.M., again knowing the distribution of both was outside the scope of professional practice and not for a legitimate medical purpose. Keller was also convicted of distributing Carisoprodol to A.M. on July 10, 2017. Approximately two weeks later, A.M. died of an overdose of Oxycodone and other drugs.

The jury convicted Keller of four counts of distributing drugs outside the scope of professional practice in violation of 21 U.S.C. §§ 841(a)(1), but was unable to reach a verdict on six counts.

Of the four counts of conviction, the counts of distributing Oxycodone carry a maximum sentence of 20 years in prison and the counts of distributing Carisoprodol and Diazepam carry a maximum sentence of five years in prison. Additional fines, restitution, and periods of supervised release may also be ordered at sentencing.

United States District Judge Vince Chhabria has not yet set a date for a sentencing hearing. Keller remains out of custody pending his sentencing hearing.

Keller was facing disciplinary charges filed by the California Medical Board when he stipulated to surrender his license in November 2019. He is no longer licensed to practice in California.

Carrier Cannot Disqualify Multiple WCJs in Dec’d Defense Attorney Case

Nicole Schilder (spouse), Isabel Marsau (daughter), and Charles Marsau (son), filed death benefits claims alleging that Donald Marsau died as a result of the repetitive and cumulative stress of his employment with Stander Reubens Thomas Kinsey, insured by defendant Valley Forge Insurance, administered by CNA Claims Plus. The two applications were filed at the Sacramento District office of the WCAB.

The employer is a workers’ compensation defense law firm. Before he died, Donald Marsau was a Certified Workers’ Compensation Law Specialist at Stander Reubens Thomas Kinsey. He practiced workers’ compensation defense principally in the Sacramento area until his death on December 4, 2021.

On February 23, 2022, defendant filed its Petition for Disqualification and Request to Transfer Venue Based on Disqualification of Judges. The Petition asked to disqualify all of the WCJs at the Sacramento and Stockton District Offices. And also requested a change of venue to a district office other than the Sacramento and Stockton District Offices.

A Report on Petition for Disqualification from the Presiding Sacramento workers’ compensation administrative law Judge recommended that the Petition for Disqualification be denied or dismissed.

A WCAB panel considered the allegations in the Petition, and the contents of the Report. Based on its review of the record, and for the reasons discussed below, it denied the Petition and returned the matter to the WCJ for further proceedings as appropriate in the case of Nicole Schilder (Donald Marsau Deceased) v Stander Reubens Thomas Kinsey – ADJ15708296 (October 2022).

Labor Code section 5311 specifically states that a party may object “to a particular workers’ compensation judge” being assigned to the case at issue. (Lab. Code, § 5311.) There is no statutory or case law that allows the disqualification of multiple WCJs by a party filing a single petition to disqualify.

The Appeals Board has previously held that parties may not seek “blanket” disqualifications, and that disqualifications must be sought on a case-by-case basis. (Robbins v. Sharp Healthcare (2006) 71 Cal.Comp.Cases 1291, 2006 Cal.Wrk.Comp. LEXIS 314 (Appeals Board significant panel).)

Further, although a petition for disqualification of a WCJ is to be determined by the Appeals Board, a petition for change of venue will initially be addressed by the Presiding WCJ at the district office where the petition is filed, and subsequently an aggrieved part may seek review by the Appeals Board. Thus the “Request to Transfer Venue” was not properly before the WCAB panel and was therefore not addressed at this time.

Thus the panel did not address the merits of the disqualification or removal. However, upon return of this matter to the trial level, if defendant seeks a change of venue from the Sacrament District Office, that issue would need to be submitted to the Sacramento Presiding WCJ. Once the proper venue has been determined and the matter has been assigned to a WCJ, defendant may seek disqualification if appropriate.

The panel also said that “It is also important to note that a party’s “unilateral” and/or “subjective” perception of an appearance of bias does not constitute a factual or legal basis for disqualification of a WCJ. (Haas v. County of San Bernardino (2002) 27 Cal.4th 1017, 1034 [119 Cal. Rptr. 2d 341] Andrews v. Agricultural Labor Relations Bd. (1981) 28 Cal. 3d 781 [171 Cal. Rptr. 590].)”

CDC Updates Opioid Clinical Treatment Guidelines

The CDC updated their recommendations for using opioids to treat pain, removing specific dose and duration targets that pain experts said had caused unintended harm.

The new 2022 Clinical Practice Guideline addresses the following areas: 1) determining whether to initiate opioids for pain, 2) selecting opioids and determining opioid dosages, 3) deciding duration of initial opioid prescription and conducting follow-up, and 4) assessing risk and addressing potential harms of opioid use.

The Clinical Practice Guideline supports the primary prevention pillar of the HHS Overdose Prevention Strategy – supporting the development and promotion of evidence-based treatments to effectively manage pain.

According to the CDC press releaseThe recommendations are voluntary and provide flexibility to clinicians and patients to support individualized, patient-centered care. They should not be used as an inflexible, one-size-fits-all policy or law or applied as a rigid standard of care or to replace clinical judgment about personalized treatment.”

CDC followed a rigorous scientific process using the best available evidence and expert consultation to develop the 2022 Clinical Practice Guideline. An independent federal advisory committee, four peer reviewers, and members of the public reviewed the draft updated guideline, and CDC revised it in response to this feedback to foster a collaborative and transparent process. CDC also engaged with patients with pain, caregivers, and clinicians to gain insights and gather feedback from people directly impacted by the guideline. The expanded guideline aims to ensure equitable access to effective, informed, individualized, and safe pain care.

The new guidance, released by the Centers for Disease Control and Prevention, reflects the evolution in thinking of how opioids should be used, and the reality of how they are being used.

According to a review of the new Guidelines by Stat News, the original guidelines, issued in 2016, helped further drive down opioid prescribing levels that had been in decline since 2012, as the country grappled with its legacy of overprescribing that contributed to the overdose epidemic.

But critics contended the 2016 guidelines, while helping limit new prescriptions, introduced other harms by leading to unsafe dose reductions for people already on opioids and some long-term patients being cut off from medication they depended on.

The authors of the original guidelines warned in 2019 that their recommendations were being misapplied. And in a commentary also published Thursday, the authors wrote that they revised their recommendations because the original document was improperly cited as a justification for certain policies that restricted opioid access.

Additional materials associated with the guideline are available for patients and clinicians.